Biogen

Anonymous board for Biogen
Post thread
ICER on Leqembi
Replies
18
Views
4K
anonymous
The benefit is questionable. The danger is real.
Replies
8
Views
3K
anonymous
ALS drug
Replies
2
Views
1K
anonymous
Clinical trial participant’s autopsy and brain exam stoke Alzheimer’s drug fears | Science | AAAS
Replies
1
Views
790
anonymous
On the Verge of Full FDA Approval, New Details About Leqembi Death | Being Patient
Replies
1
Views
916
anonymous
Struggling Biogen paid CEOs Chris Viehbacher $30.5M and Michel Vountatos $26.6M in 2022
Replies
5
Views
1K
anonymous
FiercePharma: Biogen's Alzheimer's disease sales are negative as Aduhelm fallout lingers
Replies
2
Views
1K
anonymous
Axios: New Alzheimer's drug doesn't show net benefit, report finds
Replies
2
Views
886
anonymous
New EVP of Corporate Development
Replies
3
Views
2K
anonymous
Accelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs: A Systematic Review and Meta-analysis
Replies
9
Views
2K
anonymous
Viehbacher...Really?
Replies
70
Views
19K
anonymous
Biogen And Eisai, Cassava Sciences, And Anavex: Clinical Trial Results In Need Of Revisions
Replies
2
Views
773
anonymous
Alisha bye bye
Replies
19
Views
7K
anonymous
MS Shakeup Coming
Replies
15
Views
5K
anonymous
CNBC: FDA advisors vote against effectiveness of Biogen's ALS drug
Replies
7
Views
2K
anonymous
STAT: Biogen executive Samantha Budd Haeberlein leaves company
Replies
5
Views
2K
anonymous
Get ready for the big loss
Replies
9
Views
5K
anonymous
U.S. Medicare says no change to Alzheimer's drug restrictions | Reuters
Replies
7
Views
2K
anonymous
MS division
Replies
3
Views
2K
anonymous
Leaving MS, hopefully.
Replies
0
Views
1K
anonymous
Top Bottom
Back
Post thread